Date posted: 04/22/2020
Business location: San Francisco, CA
Amount Funded: $12 Million
Type: Series A
Lead Investor: 8VC
Participating Investor(s): DCVC, DCVC Bio, Mubadala Capital Ventures
Note: Investors in red are new investors to this company.
Total Funding to Date: not listed
Company Description: Unlearn has developed the first machine learning (ML) platform for creating Intelligent Control Arms with Digital Twins through its proprietary DiGenesisᵀᴹ process, allowing drug developers to dramatically improve clinical evidence and trial power, while lowering the risk of trial failure, thereby increasing confidence in clinical trial results. Unlearn is working closely with biopharmaceutical and medical device companies as well as regulators to ensure its methods meet the highest scientific and regulatory standards.
What funding will be used for: To accelerate Unlearn.AI’s machine learning to improve clinical trial efficiency and accuracy.
Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy.